Novel tetrahydropyran analogs as dipeptidyl peptidase IV inhibitors: Profile of clinical candidate (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine (23)

被引：34

作者：

Biftu, Tesfaye ^{[1
]}

Qian, Xiaoxia ^{[1
]}

Chen, Ping ^{[1
]}

Feng, Dennis ^{[1
]}

Scapin, Giovanna ^{[1
]}

Gao, Ying-Duo ^{[1
]}

Cox, Jason ^{[1
]}

Roy, Ranabir Sinha ^{[1
]}

Eiermann, George ^{[1
]}

He, Huabing ^{[2
]}

Lyons, Kathy ^{[2
]}

Salituro, Gino ^{[2
]}

Patel, Sangita ^{[1
]}

Petrov, Alexander ^{[1
]}

Xu, Feng ^{[1
]}

Xu, Shiyao Sherrie ^{[2
]}

Zhang, Bei ^{[1
]}

Caldwell, Charles ^{[1
]}

Wu, Joseph K. ^{[1
]}

Lyons, Kathy ^{[2
]}

Weber, Ann E. ^{[1
]}

机构：

[1] Merck Res Labs, Rahway, NJ 07065 USA

[2] Merck Res Labs, PPDM Bioanalyt, Rahway, NJ 07065 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2013年 / 23卷 / 19期

关键词：

DPP-IV; Tetrahydropyran; DPP-4; inhibitors; Diabetes; RATIONAL DESIGN; IDENTIFICATION; HOMOLOG; CLONING; POTENT;

D O I：

10.1016/j.bmcl.2013.07.061

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of novel tri-2,3,5-substituted tetrahydropyran analogs were synthesized and evaluated as inhibitors of dipeptidyl peptidase IV (DPP-4) for the treatment of type 2 diabetes. Optimization of the series provided inhibitors with good DPP-4 potency and selectivity over other peptidases (QPP, DPP8, and FAP). Compound 23, which is very potent, selective, efficacious in the diabetes PD model, and has an excellent pharmacokinetic profile, is selected as a clinical candidate. (C) 2013 Elsevier Ltd. All rights reserved.

引用

页码：5361 / 5366

页数：6

共 13 条

[1] Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8
Abbott, CA
Yu, DMT
Woollatt, E
Sutherland, GR
McCaughan, GW
Gorrell, MD
[J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (20): : 6140 - 6150
[2] Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin
Biftua, Tesfaye
Scapin, Giovanna
Singh, Suresh
Feng, Dennis
Becker, Joe W.
Eiermann, George
He, Hualbing
Lyons, Kathy
Patel, Sangita
Petrov, Aleksandr
Sinha-Roy, Ranabir
Zhang, Bei
Wu, Joseph
Zhang, Xiaoping
Doss, George A.
Thornberry, Nancy A.
Weber, Ann E.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (12) : 3384 - 3387
[3] Minireview: Update on Incretin Biology: Focus on Glucagon-Like Peptide-1
Brubaker, Patricia L.
[J]. ENDOCRINOLOGY, 2010, 151 (05) : 1984 - 1989
[4] Purification, identification and characterisation of seprase from bovine serum
Collins, PJ
McMahon, G
O'Brien, P
O'Connor, B
[J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (11) : 2320 - 2333
[5] Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance
Conarello, SL
Li, ZH
Ronan, J
Roy, RS
Zhu, L
Jiang, GQ
Liu, F
Woods, J
Zycband, E
Moller, DE
Thornberry, NA
Zhang, BB
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) : 6825 - 6830
[6] Modeling assisted rational design of novel, potent, and selective pyrrolopyrimidine DPP-4 inhibitors
Gao, Ying-Duo
Feng, Dennis
Sheridan, Robert P.
Scapin, Giovanna
Patel, Sangita B.
Wu, Joseph K.
Zhang, Xiaoping
Sinha-Roy, Ranabir
Thornberry, Nancy A.
Weber, Ann E.
Biftu, Tesfaye
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (14) : 3877 - 3879
[7] Havale J. J., 2009, MOL CELL ENDOCRINOL, V297, P127
[8] Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes
Havale, Shrikanth H.
Pal, Manojit
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (05) : 1783 - 1802
[9] Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes - Potential importance of selectivity over dipeptidyl peptidases 8 and 9
Lankas, GR
Leiting, B
Roy, RS
Eiermann, GJ
Beconi, MG
Biftu, T
Chan, CC
Edmondson, S
Feeney, WP
He, HB
Ippolito, DE
Kim, D
Lyons, KA
Ok, HO
Patel, RA
Petrov, AN
Pryor, KA
Qian, XX
Reigle, L
Woods, A
Wu, JK
Zaller, D
Zhang, XP
Zhu, L
Weber, AE
Thornberry, NA
[J]. DIABETES, 2005, 54 (10) : 2988 - 2994
[10] Rate-correction technique for QT interval in long-term telemetry ECG recording in beagle dogs
Miyazaki, H
Tagawa, M
[J]. EXPERIMENTAL ANIMALS, 2002, 51 (05) : 465 - 475

← 1 2 →